Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy
Advanced Science · 2024
DOI: 10.1002/advs.202400188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Alastair Khodabukus und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA. Hauptthemen laut MEDLINE: Muscular Dystrophies, Limb-Girdle, Calcium, Muscle, Skeletal. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIAMS NIH HHS, Jain Foundation.
Abstract (Originalsprache)
Dysferlin is a multi‐functional protein that regulates membrane resealing, calcium homeostasis, and lipid metabolism in skeletal muscle. Genetic loss of dysferlin results in limb girdle muscular dystrophy 2B/2R (LGMD2B/2R) and other dysferlinopathies – rare untreatable muscle diseases that lead to permanent loss of ambulation in humans. The mild disease severity in dysferlin‐deficient mice and diverse genotype‐phenotype relationships in LGMD2B patients have prompted the development of new in vitro models for personalized studies of dysferlinopathy. Here the first 3‐D tissue‐engineered hiPSC‐derived skeletal muscle (“myobundle”) model of LGMD2B is described that exhibits compromised contractile function, calcium‐handling, and membrane repair, and transcriptomic changes indicative of impaired oxidative metabolism and mitochondrial dysfunction. In response to the fatty acid (FA) challenge, LGMD2B myobundles display mitochondrial deficits and intracellular lipid droplet (LD) accumulation. Treatment with the ryanodine receptor (RyR) inhibitor dantrolene or the dissociative glucocorticoid vamorolone restores LGMD2B contractility, improves membrane repair, and reduces LD accumulation. Lastly, it is demonstrated that chemically induced chronic RyR leak in healthy myobundles phenocopies LGMD2B contractile and metabolic deficit, but not the loss of membrane repair capacity. Together, these results implicate intramyocellular Ca 2+ leak as a critical driver of dysferlinopathic phenotype and validate the myobundle system as a platform to study LGMD2B pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
- Duke Molecular Physiology Institute, Duke University, Durham, NC, 27708, USA.
ORCID-Profile: Alastair Khodabukus, Nenad Bursac
Förderung
- NCATS NIH HHS
- NIAMS NIH HHS
- Jain Foundation
- NIH HHS
- NIGMS NIH HHS
- NIBIB NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Khodabukus, A., Prabhu, N. K., Roberts, T., Buldo, M., Detwiler, A., Fralish, Z. D., Kondash, M. E., Truskey, G. A., Koves, T. R., & Bursac, N. (2024). Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy. Advanced Science. https://doi.org/10.1002/advs.202400188
Vancouver
Khodabukus A, Prabhu NK, Roberts T, Buldo M, Detwiler A, Fralish ZD, et al. Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy. Advanced Science. 2024. doi:10.1002/advs.202400188
BibTeX
@article{Khodabukus2024,
author = {Khodabukus, Alastair and Prabhu, Neel K and Roberts, Taylor and Buldo, Meghan and Detwiler, Amber and Fralish, Zachary D and Kondash, Megan E and Truskey, George A and Koves, Timothy R and Bursac, Nenad},
title = {Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202400188}
}
EUVIMED